1 |
Zhu M, Qin ZJ, Hu D, Munishkina LA, Fink AL. Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles. Biochemistry 2006. 45: 8135-8142.
DOI
ScienceOn
|
2 |
Maries E, Dass B, Collier TJ, Kordower JH, Steece-Collier K. The role of alpha-synuclein in parkinson's disease: insights from animal models. Nat Rev Neurosci. 2003. 4: 727-738.
DOI
ScienceOn
|
3 |
Perrin RJ, Woods WS, Clayton DF, George JM. Interaction of human alpha-synuclein and parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem. 2000. 275: 34393-34398.
DOI
|
4 |
Sharon R, Bar-Joseph I, Mirick GE, Serhan CN, Selkoe DJ. Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alphasynucleinopathies. J Biol Chem. 2003. 278: 49874-49881.
DOI
|
5 |
Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K. Alpha-synuclein locus triplication causes parkinson's disease. Science 2003. 302: 841.
DOI
ScienceOn
|
6 |
Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang Y, Hay JC. Alpha-synuclein delays endoplasmic reticulum(ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol Biol Cell. 2010. 21: 1850-1863.
DOI
|
7 |
Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC, Petrlova J, Voss JC, Stamou DG, Steven AC, Langen R. Membrane curvature induction and tabulation are common features of synucleins and apolipoproteins. J Biol Chem. 2010. 285: 32486-32493.
DOI
|
8 |
Castagnet PI, Golovko MY, Barcelo-Coblijn GC, Nussbaum RL, Murphy EJ. Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem. 2005. 94: 839-849.
DOI
ScienceOn
|
9 |
Darios F, Ruiperez V, Lopez I, Villanueva J, Gutierrez LM, Davletov B. Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep. 2010. 11: 528-533.
DOI
ScienceOn
|
10 |
Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998. 273: 9443-9449.
DOI
|
11 |
Golovko MY, Faergeman NJ, Cole NB, Castagnet PI, Nussbaum RL, Murphy EJ. Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding. Biochemistry 2005. 44: 8251-8259.
DOI
ScienceOn
|
12 |
Kim YS, Laurine E, Woods W, Lee SJ. A novel mechanism of interaction between alpha-synuclein and biological membranes. J Mol Biol. 2006. 360: 386-397.
DOI
ScienceOn
|
13 |
Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Sudhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010. 329: 1663-1667.
DOI
|
14 |
Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with parkinson's disease. Science 1997. 276: 2045-2047.
DOI
|